Naloxone and morphine inhibit gastric emptying of solids.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 7104860)

Published in Can J Physiol Pharmacol on May 01, 1982

Authors

M C Champion, S N Sullivan, M Chamberlain, W Vezina

Articles by these authors

The sor gene of HIV-1 is required for efficient virus transmission in vitro. Science (1987) 6.16

Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost (2000) 4.81

Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med (1998) 2.49

The cytotoxic effects of asbestos and other mineral dust in tissue culture cell lines. Br J Exp Pathol (1978) 2.45

Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis. J Clin Oncol (1999) 2.29

The effect of fibre size on the in vitro biological activity of three types of amphibole asbestos. Int J Cancer (1978) 2.24

Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncol (2011) 2.13

Aortoenteric fistula. Incidence, presentation recognition, and management. Ann Surg (1982) 1.97

Enkephalin-like immunoreactivity in the human gastrointestinal tract. Lancet (1977) 1.75

Measuring gastric contents during general anaesthesia: evaluation of blind gastric aspiration. Can J Anaesth (1989) 1.60

A double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia. The Canadian Cisapride Nud Study Group. Can J Gastroenterol (1997) 1.51

Biological effects of tremolite. Br J Cancer (1982) 1.50

Interest in alternative birthplaces among women in Ottawa-Carleton. CMAJ (1990) 1.50

Effects of erythromycin on gut transit in pseudo-obstruction due to hereditary coproporphyria. J Clin Gastroenterol (1992) 1.48

Mapping the transcriptional transactivation function of simian virus 40 large T antigen. J Virol (1991) 1.47

Specific localisation of neurotensin to the N cell in human intestine by radioimmunoassay and immunocytochemistry. Nature (1977) 1.47

Hypertonicity of the cricopharyngeal sphincter: A cause of globus sensation. Lancet (1974) 1.41

Continuous subcutaneous infusion of insulin in the management of diabetes mellitus. Diabetes (1980) 1.35

The gastrointestinal symptoms of running. N Engl J Med (1981) 1.35

Globus and headache: common symptoms of the irritable bowel syndrome. Can Med Assoc J (1978) 1.35

Asbestos and glass fibres in bacterial mutation tests. Mutat Res (1977) 1.35

Is cimetidine being prescribed indiscriminately? An analytic survey of patients who present with symptoms of peptic ulcer disease. Can Med Assoc J (1984) 1.25

Midgut volvulus in the adult. A complication of intestinal malrotation. J Clin Gastroenterol (1987) 1.20

Bicalutamide monotherapy compared with castration in patients with nonmetastatic locally advanced prostate cancer: 6.3 years of followup. J Urol (2000) 1.20

In vitro prediction of the pathogenicity of mineral dusts. Br J Exp Pathol (1979) 1.19

Casodex (bicalutamide) 150-mg monotherapy compared with castration in patients with previously untreated nonmetastatic prostate cancer: results from two multicenter randomized trials at a median follow-up of 4 years. Urology (1998) 1.16

A randomised comparison of 'Casodex' (bicalutamide) 150 mg monotherapy versus castration in the treatment of metastatic and locally advanced prostate cancer. Eur Urol (1998) 1.13

Spontaneous pseudomembranous colitis. Br Med J (1980) 1.12

Continuous subcutaneous insulin infusion (CSII) does not prevent progression of proliferative and preproliferative retinopathy. Br J Ophthalmol (1982) 1.11

Treatment of CNS dissemination in systemic lymphoma. J Neurooncol (2007) 1.05

In vitro biological effects of glass fibers. J Environ Pathol Toxicol (1980) 1.02

Phase I trial of sorafenib in patients with recurrent or progressive malignant glioma. Neuro Oncol (2011) 1.01

The in vitro activities of pathogenic mineral dusts. Toxicology (1980) 0.97

Simian virus 40 host range/helper function mutations cause multiple defects in viral late gene expression. J Virol (1989) 0.97

National survey of radionuclide gastric emptying studies. Can J Gastroenterol (1997) 0.97

Severe diarrhea due to Clostridium sphenoides: a case report. Can Med Assoc J (1980) 0.96

The use of magnetic resonance imaging in exertional compartment syndromes. Am J Sports Med (1990) 0.95

In vitro tests for the pathogenicity of mineral dusts. Ann Occup Hyg (1982) 0.95

The Second Canadian Consensus Conference on the Management of Patients with Gastroesophageal Reflux Disease. Can J Gastroenterol (1997) 0.94

Cross-talk between signalling pathways and the multidrug resistant protein MDR-1. Br J Cancer (2001) 0.94

Hemobilia after percutaneous liver biopsy: role of endoscopic retrograde cholangiopancreatography and sphincterotomy. Am J Gastroenterol (1983) 0.93

Quantitative measurement of quality outcome in malignant glioma patients using an independent living score (ILS). Assessment of a retrospective cohort. J Neurooncol (2003) 0.92

The activity of two types of asbestos in tissue culture. IARC Sci Publ (1980) 0.92

The gut hormone profile of fulminant hepatic failure. Am J Gastroenterol (1981) 0.91

Vertebral collapse with quadraparesis due to metastatic gliobla multiforme: case report and review of the literature. J Neurooncol (1993) 0.91

Using the OSCE to measure clinical skills performance in nursing. J Adv Nurs (1988) 0.91

Association of dietary fish and n-3 fatty acid intake with hemostatic factors in the coronary artery risk development in young adults (CARDIA) study. Arterioscler Thromb Vasc Biol (1998) 0.90

Effects of acute graded exercise on human colonic motility. Am J Physiol (1999) 0.90

Enkephalin in peripheral neuroendocrine tumours. Lancet (1978) 0.90

Simple method for repeated blood-sampling. Lancet (1980) 0.89

Expression of Epstein-Barr virus proteins in primary CNS lymphoma in AIDS patients. Neurology (1993) 0.88

The effect of running on the gastrointestinal tract. J Clin Gastroenterol (1984) 0.88

Measuring nursing support during childbirth. MCN Am J Matern Child Nurs (2001) 0.87

Changes in rat serum corticosterone after treatment with metabotropic glutamate receptor agonists or antagonists. J Neuroendocrinol (2001) 0.87

Domperidone, a new dopamine antagonist. CMAJ (1986) 0.86

Effect of cimetidine on lower oesophageal sphincter. Br Med J (1976) 0.86

Conference on insulin pump therapy in diabetes. Multicenter study of effect on microvascular disease. Origin and design of the Kroc Collaborative Study. Diabetes (1985) 0.86

Aortoduodenal fistula; endoscopic diagnosis. Dig Dis Sci (1980) 0.86

Protective vaccination against virulent Babesia bovis with a low-molecular-weight antigen. Infect Immun (1985) 0.85

An alternative strategy to the use of guinea pigs for the identification of skin sensitization hazard. Food Chem Toxicol (1995) 0.85

Effect of mineral dusts on metabolic cooperation between Chinese hamster V79 cells in vitro. Environ Health Perspect (1983) 0.84

Hypergastrinemia and gastric acid hypersecretion in uremia. Clin Nephrol (1976) 0.84

Chest pain--esophageal, cardiac, or both? Am J Gastroenterol (1985) 0.84

A summary report of the COLIPA international validation study on alternatives to the draize rabbit eye irritation test. Toxicol In Vitro (2010) 0.83

Leptomeningeal metastases due to melanoma. Int J Oncol (1996) 0.83

The classification of skin irritants by human patch test. Food Chem Toxicol (1997) 0.83

Gastrointestinal dysfunction in multiple sclerosis. Gastroenterology (1983) 0.83

Heritability of the spatial distribution and peak density of macular pigment: a classical twin study. Eye (Lond) (2012) 0.82

The effect of naloxone, morphine, and an enkephalin analogue on cholecystokinin octapeptide-stimulated gallbladder emptying. Am J Gastroenterol (1982) 0.82

Budd-Chiari syndrome with inferior vena cava obstruction associated with systemic lupus erythematosus. J Clin Gastroenterol (1984) 0.82

Observations on control of glycemia with conventional insulin therapy or continuous subcutaneous insulin infusion. Diabetes (1985) 0.82

The influence of mineral dusts on metabolic co-operation between mammalian cells in tissue culture. Carcinogenesis (1982) 0.82

Male pattern baldness. South Med J (2000) 0.82

T-cell infiltration of primary CNS lymphoma. Neurology (1996) 0.81

The midclavicular line: a wandering landmark. CMAJ (1987) 0.81

Accuracy of capillary blood glucose values self-determined by diabetics under everyday conditions: comparison of visually-read and meter-read techniques. Clin Invest Med (1982) 0.81

Validation of skin sensitization assays. Food Chem Toxicol (1995) 0.80

Gastrointestinal bleeding in distance runners. Sports Med (1986) 0.80

Testing protocol and recruitment in the genes in myopia twin study. Ophthalmic Epidemiol (2008) 0.80

In vitro effects of man-made mineral fibres. Ann Occup Hyg (1979) 0.80

Phosphoinositide hydrolysis in vivo with group I metabotropic glutamate receptor agonists. Brain Res (1999) 0.80

A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients. J Neurooncol (2016) 0.80

Management of the irritable bowel syndrome: a personal view. J Clin Gastroenterol (1983) 0.79

The effect and mode of action of zinc pyrithione on cell growth. I. In vitro studies. Food Chem Toxicol (1985) 0.79

Induction of molecular remission by donor peripheral blood leukocyte therapy in patients relapsing with extramedullary blastic phase chronic myeloid leukemia after allogeneic bone marrow transplantation. Oncol Rep (1998) 0.79

Radioaerosol ventilation imaging in ventilator-dependent patients. Technical considerations. Clin Nucl Med (1985) 0.79

Phase I/II study of intraventricular and intrathecal ACNU for leptomeningeal neoplasia. Cancer Chemother Pharmacol (1989) 0.79

Cutaneous hypersensitivity to vitamin K1 injection. J Am Acad Dermatol (1987) 0.79

An expert system rulebase for identifying contact allergens. Toxicol In Vitro (1994) 0.79

Naloxone and Prader-Willi syndrome. Lancet (1980) 0.79

Variability in the clinical presentation and endoscopic findings of herpetic esophagitis. Endoscopy (1987) 0.79

Reduction by morphine of human postprandial insulin release is secondary to inhibition of gastrointestinal motility. Diabetes (1986) 0.79

Identification of irritation and corrosion hazards to skin: an alternative strategy to animal testing. Food Chem Toxicol (1994) 0.78

Onions and dyspepsia. Am J Gastroenterol (1990) 0.78

Cytotoxic action of mineral dusts on CHV 79 cells in vitro: factors affecting toxicity. Environ Health Perspect (1983) 0.78

Modulation of stress-induced and stimulated hyperprolactinemia with the group II metabotropic glutamate receptor selective agonist, LY379268. Neuropharmacology (2002) 0.78